GlassScriptPhysician profile
Frank Gredler
NPI 1023013661
$3,181.25
in general payments reported to CMS, 2019-2025
26 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $287 · 2021: $361 · 2022: $649 · 2023: $829 · 2024: $410 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,415.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $402.56 | 2019-2023 | Xarelto |
| Medtronic, INC. | $398.08 | 2021-2024 | Corevalve Evolut R, Onyx Frontier, Arctic Front Advance |
| Inari Medical, INC. | $390.94 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $268.80 | 2019-2020 | |
| Boston Scientific Corporation | $228.61 | 2019-2025 | Emblem Mri S-Icd, Endotak Reliance S, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $212.48 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $198.46 | 2022-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $177.88 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $137.71 | 2022 | |
| Amgen INC. | $110.99 | 2020-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.60 | 2022 | |
| Silk Road Medical, INC. | $95.60 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Heartflow, INC. | $86.25 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.21 | 2021-2025 | Camzyos |
| Penumbra, INC. | $51.40 | 2025 | Indigo System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $39.66 | 2019 | |
| Biotronik INC. | $39.20 | 2019 | |
| Abbott Laboratories | $32.81 | 2023-2025 | Viewmate, Navitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.12 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $23.88 | 2021 | |
| Shockwave Medical, INC | $22.77 | 2025 | |
| Stryker Corporation | $19.02 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Elutia, INC. | $16.83 | 2024 | Ecm Patch,Pouch |
| Ethicon US, LLC | $15.95 | 2023 | Vistaseal, Dermabond |
| Alexion Pharmaceuticals, INC. | $15.44 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Gredler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.